Keeping our key goal on drug target identification, our analysis methods allow finding of currently activated targets in the examined patient data and selection of the best fit therapy for every studied case.
Genome Enhancer is a fully automated pipeline for patient’s multi-omics data analysis. It generates a comprehensive report about the personalized drug targets identified for a certain patient, or a group of patients, and the drugs that may be effective in this case. Proven applications include cancer, neurodegenerative diseases, infectious diseases, diabetes and metabolic diseases, hypertension. Genome Enhancer is using TRANSFAC®, TRANSPATH® and HumanPSD™ databases for the performed analysis. Learn more about Genome Enhancer.